Braskem (NYSE: BAK)

$2.46+2.50%today

Brazilian ADR trading on the NYSE, priced in US dollars. Key figures below are sourced from Yahoo Finance.

Market Cap: $980.27M
P/E (TTM): —
P/B: -0.3x
EPS (TTM): -4.42
Dividend Yield: —
52-Week Range: $2.25 – $5.39
Volume: 1.45M
Previous Close: $2.40

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today

+2.50%

1 Week

-9.23%

1 Month

-16.33%

YTD

-16.61%

1 Year

-19.08%

5 Years

-89.30%

About Braskem

US Ticker: BAK
B3 Ticker: BRKM5
Exchange: NYSE
Currency: USD
Sector: Basic Materials
Industry: Chemicals
Headquarters: São Paulo, SP, Brazil
Employees: 8,233
CEO: Dr. Helcio Tokeshi
Founded: 1972

Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil.

The company supplies electricity and other inputs to second-generation producers; sells utilities, such as steam, water, compressed air and industrial gases; industrial services; and engages in the production, supply, and sale of electric energy and gas.

It also produces and sells polyethylene, including the production of green PE made from renewable resources, and polypropylene; and polyvinyl chloride and caustic soda.

In addition, the company provides thermoplastic resins; and other basic petrochemicals.

It has operations in the United States, Europe, Asia, and internationally.

The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002.

Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil.

www.braskem.com.br

Analyst Ratings

Consensus of 5 Wall Street analysts · sourced from Yahoo Finance

3.2Hold

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low

$1.50

Average

$3.40

High

$6.50

The average target is +38.39% above the current price of $2.46.

Display currency

Revenue, net debt and other totals below — switch between US dollars and BRL.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from Braskem's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Stretched

Net Margin: -13.7%
ROE: 58.8%
Rev Growth (YoY): -3.73%
Net Debt / EBITDA: 8.98×
Current Ratio: 0.71×
Interest Coverage: 0.38×
Free Cash Flow: -9.20B
Payout Ratio: —

Income — Margins & Efficiency

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Revenue	$12,853,373,902	+1.5%	$12,659,853,913	+1.0%	$12,530,309,652	-13.9%	$14,549,709,290	-20.3%	$18,264,201,643	-3.7%	$18,962,514,811	+68.1%	$11,278,233,442	-13.4%	$13,029,703,831	-13.0%	$14,970,798,100	+0.6%	$14,877,533,146	+1.5%	$14,655,470,898	+22.6%	$11,950,108,929	-31.1%	$17,343,502,129	-0.1%	$17,365,104,056	-0.0%	$17,365,115,153	-2.4%	$17,786,918,293	+16.0%	$15,339,841,757	+75.3%	$8,748,328,170	+13.2%	$7,727,839,931	-22.7%	$10,002,796,684	+64.5%	$6,082,263,262
Gross profit	$259,205,053	-6.9%	$278,557,211	-71.3%	$970,718,205	+55.8%	$622,860,913	-71.0%	$2,149,263,899	-62.7%	$5,755,089,584	+169.2%	$2,137,582,576	+33.2%	$1,604,798,503	-46.4%	$2,992,197,357	-23.0%	$3,883,905,651	-0.7%	$3,912,114,196	+49.1%	$2,623,628,276	+16.6%	$2,250,875,250	+3.1%	$2,182,312,126	+35.1%	$1,615,294,607	-21.9%	$2,068,522,947	-15.8%	$2,456,703,971	+65.7%	$1,482,226,047	+22.2%	$1,212,865,749	-33.8%	$1,832,248,214	+77.9%	$1,030,165,618
Operating income	-$383,415,498	+46.8%	-$721,277,163	-540.3%	$163,809,709	+145.4%	-$360,809,864	-131.2%	$1,156,568,141	-76.3%	$4,879,896,593	+260.9%	$1,352,217,821	+3111.3%	$42,107,612	-98.0%	$2,143,395,540	-24.2%	$2,826,553,109	+54.5%	$1,829,857,947	+2.7%	$1,782,341,598	+32.5%	$1,344,790,324	+15.8%	$1,161,327,936	+54.4%	$752,336,316	-27.3%	$1,034,690,650	-46.5%	$1,934,392,900	+70.3%	$1,135,895,009	+121.1%	$513,769,363	-45.0%	$934,852,242	+90.2%	$491,629,812
EBITDA	$1,333,769,835	+1056.9%	$115,289,799	-73.6%	$436,394,244	-35.2%	$672,961,940	-56.1%	$1,534,269,387	-66.3%	$4,547,413,019	+132.2%	$1,958,058,225	+305.2%	$483,203,846	-79.8%	$2,392,802,385	-31.4%	$3,485,932,470	+110.1%	$1,658,893,091	-32.4%	$2,452,386,838	+21.8%	$2,013,602,728	-1.0%	$2,034,176,239	+278.7%	$537,144,394	-77.3%	$2,370,080,420	-10.3%	$2,641,548,135	+34.0%	$1,971,784,280	+605.3%	-$390,246,988	-123.5%	$1,659,027,896	+71.2%	$969,215,746
Net profit	-$1,758,588,815	+0.6%	-$1,768,731,054	+3.5%	-$1,832,337,849	-94.1%	-$944,084,780	-1384.9%	-$63,580,971	-102.5%	$2,510,681,843	+294.8%	-$1,289,140,349	-103.7%	-$632,763,414	-185.5%	$739,939,859	-40.0%	$1,233,124,943	+1074.7%	-$126,517,234	-115.9%	$793,669,219	+143.8%	$325,558,193	+50.7%	$216,037,384	+160.4%	-$357,509,657	-27.0%	-$281,547,287	-124.7%	$1,140,378,460	+116.7%	$526,235,227	+149.1%	-$1,072,332,186	-446.1%	$309,825,482	+553.3%	$47,421,356
Gross margin	2.0%	-0.2 p.p.	2.2%	-5.5 p.p.	7.7%	+3.5 p.p.	4.3%	-7.5 p.p.	11.8%	-18.6 p.p.	30.3%	+11.4 p.p.	19.0%	+6.6 p.p.	12.3%	-7.7 p.p.	20.0%	-6.1 p.p.	26.1%	-0.6 p.p.	26.7%	+4.7 p.p.	22.0%	+9.0 p.p.	13.0%	+0.4 p.p.	12.6%	+3.3 p.p.	9.3%	-2.3 p.p.	11.6%	-4.4 p.p.	16.0%	-0.9 p.p.	16.9%	+1.2 p.p.	15.7%	-2.6 p.p.	18.3%	+1.4 p.p.	16.9%
Operating margin	-3.0%	+2.7 p.p.	-5.7%	-7.0 p.p.	1.3%	+3.8 p.p.	-2.5%	-8.8 p.p.	6.3%	-19.4 p.p.	25.7%	+13.7 p.p.	12.0%	+11.7 p.p.	0.3%	-14.0 p.p.	14.3%	-4.7 p.p.	19.0%	+6.5 p.p.	12.5%	-2.4 p.p.	14.9%	+7.2 p.p.	7.8%	+1.1 p.p.	6.7%	+2.4 p.p.	4.3%	-1.5 p.p.	5.8%	-6.8 p.p.	12.6%	-0.4 p.p.	13.0%	+6.3 p.p.	6.6%	-2.7 p.p.	9.3%	+1.3 p.p.	8.1%
EBITDA margin	10.4%	+9.5 p.p.	0.9%	-2.6 p.p.	3.5%	-1.1 p.p.	4.6%	-3.8 p.p.	8.4%	-15.6 p.p.	24.0%	+6.6 p.p.	17.4%	+13.7 p.p.	3.7%	-12.3 p.p.	16.0%	-7.4 p.p.	23.4%	+12.1 p.p.	11.3%	-9.2 p.p.	20.5%	+8.9 p.p.	11.6%	-0.1 p.p.	11.7%	+8.6 p.p.	3.1%	-10.2 p.p.	13.3%	-3.9 p.p.	17.2%	-5.3 p.p.	22.5%	+27.6 p.p.	-5.0%	-21.6 p.p.	16.6%	+0.7 p.p.	15.9%
Net margin	-13.7%	+0.3 p.p.	-14.0%	+0.7 p.p.	-14.6%	-8.1 p.p.	-6.5%	-6.1 p.p.	-0.3%	-13.6 p.p.	13.2%	+24.7 p.p.	-11.4%	-6.6 p.p.	-4.9%	-9.8 p.p.	4.9%	-3.3 p.p.	8.3%	+9.2 p.p.	-0.9%	-7.5 p.p.	6.6%	+4.8 p.p.	1.9%	+0.6 p.p.	1.2%	+3.3 p.p.	-2.1%	-0.5 p.p.	-1.6%	-9.0 p.p.	7.4%	+1.4 p.p.	6.0%	+19.9 p.p.	-13.9%	-17.0 p.p.	3.1%	+2.3 p.p.	0.8%
Revenue growth (YoY)	-3.7%	+6.7 p.p.	-10.4%	-20.1 p.p.	9.7%	+36.6 p.p.	-26.9%	-18.3 p.p.	-8.6%	-89.0 p.p.	80.4%	+68.5 p.p.	11.9%	+21.7 p.p.	-9.8%	-27.5 p.p.	17.7%	+14.4 p.p.	3.4%	+2.5 p.p.	0.8%	-1.9 p.p.	2.7%	-9.6 p.p.	12.4%	-3.0 p.p.	15.4%	+8.3 p.p.	7.0%	-23.1 p.p.	30.1%	-37.1 p.p.	67.2%	+82.3 p.p.	-15.1%	-16.7 p.p.	1.6%	-34.8 p.p.	36.4%	—	—
Effective tax rate	-282.1%	+3.2 p.p.	-285.3%	-317.3 p.p.	32.0%	+11.0 p.p.	21.0%	-1825.8 p.p.	1846.8%	+1824.5 p.p.	22.3%	-5.3 p.p.	27.6%	-15.1 p.p.	42.6%	+22.2 p.p.	20.4%	-3.4 p.p.	23.9%	+463.9 p.p.	-440.0%	-476.4 p.p.	36.4%	-1.9 p.p.	38.4%	-9.0 p.p.	47.4%	+4.1 p.p.	43.3%	+2.3 p.p.	40.9%	+41.0 p.p.	-0.1%	-50.5 p.p.	50.3%	+40.1 p.p.	10.3%	-21.6 p.p.	31.8%	+46.0 p.p.	-14.2%
Interest coverage	0.38×	+155.4%	-0.68×	-248.5%	-0.19×	+52.1%	-0.41×	-140.0%	1.01×	-84.7%	6.63×	-31.9%	9.73×	+569.7%	-2.07×	-174.5%	2.78×	-23.0%	3.61×	+205.7%	1.18×	-71.3%	4.12×	+73.3%	2.38×	+4.9%	2.26×	+383.0%	-0.80×	-206.0%	0.76×	-54.0%	1.64×	-56.0%	3.73×	+196.1%	-3.88×	-212.4%	3.45×	-5.5%	3.65×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Net debt	$11,977,668,888	+7.9%	$11,099,755,305	+16.7%	$9,507,437,802	+0.9%	$9,426,827,760	+23.6%	$7,629,527,306	-5.2%	$8,052,244,623	-8.5%	$8,803,951,346	-24.5%	$11,663,159,027	+39.4%	$8,369,273,656	-11.6%	$9,469,534,898	+4.1%	$9,094,443,010	+1.9%	$8,921,300,832	-6.7%	$9,558,324,856	+14.0%	$8,386,067,478	+38.4%	$6,057,399,638	-7.4%	$6,538,823,719	+7.6%	$6,079,552,347	+49.3%	$4,071,395,869	+0.9%	$4,033,777,969	+9.8%	$3,672,984,259	+51.4%	$2,426,079,504
Net Debt / Equity	-4.00×	-6.2%	-3.77×	+72.6%	-13.73×	-198.5%	13.94×	+111.2%	6.60×	-8.7%	7.23×	+161.2%	-11.82×	-243.6%	8.23×	+50.1%	5.49×	-4.3%	5.73×	-66.7%	17.19×	-54.0%	37.33×	+767.4%	4.30×	+67.1%	2.58×	+79.9%	1.43×	+16.8%	1.23×	+26.2%	0.97×	-35.1%	1.50×	-41.3%	2.55×	+149.4%	1.02×	-14.6%	1.20×
Net Debt / EBITDA	8.98×	-90.7%	96.28×	+341.9%	21.79×	+55.5%	14.01×	+181.7%	4.97×	+180.8%	1.77×	-60.6%	4.50×	-81.4%	24.14×	+590.1%	3.50×	+28.8%	2.72×	-50.4%	5.48×	+50.7%	3.64×	-23.4%	4.75×	+15.1%	4.12×	-63.4%	11.28×	+308.8%	2.76×	+19.9%	2.30×	+11.5%	2.06×	+120.0%	-10.34×	-566.9%	2.21×	-11.6%	2.50×
Debt / Equity	-4.30×	+2.7%	-4.42×	+74.4%	-17.23×	-194.3%	18.27×	+111.4%	8.64×	+0.1%	8.63×	+156.0%	-15.40×	-273.2%	8.89×	+38.5%	6.42×	+0.1%	6.42×	-69.6%	21.08×	-52.9%	44.78×	+799.0%	4.98×	+58.6%	3.14×	+73.3%	1.81×	+18.7%	1.53×	+24.8%	1.22×	-40.6%	2.06×	-36.8%	3.26×	+147.0%	1.32×	-15.1%	1.55×
Current ratio	0.71×	-6.3%	0.76×	-42.2%	1.31×	-14.3%	1.53×	+7.3%	1.42×	-8.7%	1.56×	+29.5%	1.20×	+28.1%	0.94×	+1.6%	0.93×	-1.4%	0.94×	+33.0%	0.71×	-31.4%	1.03×	-1.9%	1.05×	-5.0%	1.10×	+10.0%	1.00×	-10.7%	1.12×	+8.2%	1.04×	+7.3%	0.97×	-5.2%	1.02×	-8.5%	1.11×	+3.1%	1.08×
Return on equity (ROE)	58.8%	-1.3 p.p.	60.0%	-204.6 p.p.	264.6%	+404.3 p.p.	-139.6%	-134.1 p.p.	-5.5%	-230.9 p.p.	225.4%	+52.4 p.p.	173.1%	+217.7 p.p.	-44.7%	-93.2 p.p.	48.5%	-26.1 p.p.	74.6%	+98.5 p.p.	-23.9%	-356.0 p.p.	332.1%	+317.5 p.p.	14.7%	+8.0 p.p.	6.6%	+15.1 p.p.	-8.5%	-3.2 p.p.	-5.3%	-23.5 p.p.	18.2%	-1.1 p.p.	19.3%	+87.1 p.p.	-67.7%	-76.3 p.p.	8.6%	+6.3 p.p.	2.3%
Return on assets (ROA)	-12.2%	-0.4 p.p.	-11.8%	-0.7 p.p.	-11.1%	-6.2 p.p.	-5.0%	-4.6 p.p.	-0.4%	-15.5 p.p.	15.1%	+22.9 p.p.	-7.8%	-3.0 p.p.	-4.8%	-9.6 p.p.	4.8%	-2.9 p.p.	7.7%	+8.5 p.p.	-0.8%	-6.0 p.p.	5.2%	+3.4 p.p.	1.7%	+0.7 p.p.	1.1%	+2.9 p.p.	-1.8%	-0.4 p.p.	-1.4%	-6.9 p.p.	5.5%	+1.3 p.p.	4.1%	+15.1 p.p.	-11.0%	-13.6 p.p.	2.6%	+2.0 p.p.	0.6%
Book value / share	$-7.51	-1.6%	$-7.39	-325.5%	$-1.74	-202.4%	$1.70	-41.5%	$2.90	+3.8%	$2.79	+249.3%	$-1.87	-152.6%	$3.56	-7.1%	$3.83	-7.7%	$4.15	+212.2%	$1.33	+121.6%	$0.60	-89.2%	$5.58	-31.8%	$8.18	-23.0%	$10.63	-20.5%	$13.37	-23.6%	$17.51	+65.7%	$10.56	+69.3%	$6.24	-62.4%	$16.61	+51.7%	$10.95

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

Dividend History

Dividends and yield from Yahoo Finance (per ADR share, in USD). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.